Mirador Capital Partners’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.34M | Sell |
9,845
-198
| -2% | -$41.1K | 0.29% | 63 |
|
|
2026
Q1 | $2.12M | Buy |
10,043
+317
| +3% | +$68.3K | 0.3% | 58 |
|
|
2025
Q4 | $2M | Sell |
9,726
-4,262
| -30% | -$802K | 0.27% | 66 |
|
|
2025
Q3 | $2.2M | Sell |
13,988
-69
| -0.5% | -$10.7K | 0.31% | 61 |
|
|
2025
Q2 | $2.36M | Buy |
14,057
+563
| +4% | +$83.6K | 0.38% | 49 |
|
|
2025
Q1 | $1.86M | Buy |
13,494
+65
| +0.5% | +$8.29K | 0.33% | 58 |
|
|
2024
Q4 | $1.59M | Buy |
13,429
+466
| +4% | +$54.4K | 0.29% | 58 |
|
|
2024
Q3 | $1.43M | Buy |
12,963
+512
| +4% | +$53.5K | 0.26% | 62 |
|
|
2024
Q2 | $1.22M | Buy |
12,451
+597
| +5% | +$60.8K | 0.23% | 67 |
|
|
2024
Q1 | $1.33M | Buy |
11,854
+646
| +6% | +$69.7K | 0.25% | 66 |
|
|
2023
Q4 | $1.13M | Buy |
11,208
+531
| +5% | +$52.7K | 0.24% | 70 |
|
|
2023
Q3 | $927K | Buy |
10,677
+480
| +5% | +$43.4K | 0.21% | 81 |
|
|
2023
Q2 | $964K | Sell |
10,197
-83
| -0.8% | -$7.01K | 0.23% | 80 |
|
|
2023
Q1 | $776K | Buy |
10,280
+755
| +8% | +$57K | 0.18% | 83 |
|
|
2022
Q4 | $732K | Buy |
9,525
+140
| +1% | +$10.6K | 0.17% | 88 |
|
|
2022
Q3 | $626K | Sell |
9,385
-143
| -2% | -$9.06K | 0.15% | 90 |
|
|
2022
Q2 | $498K | Buy |
9,528
+649
| +7% | +$36.9K | 0.12% | 121 |
|
|
2022
Q1 | $503K | Buy |
8,879
+2,149
| +32% | +$115K | 0.1% | 140 |
|
|
2021
Q4 | $347K | Sell |
6,730
-401
| -6% | -$19.7K | 0.07% | 172 |
|
|
2021
Q3 | $353K | Buy |
7,131
+27
| +0.4% | +$1.47K | 0.08% | 166 |
|
|
2021
Q2 | $406K | Buy |
7,104
+632
| +10% | +$36.9K | 0.09% | 153 |
|
|
2021
Q1 | $393K | Sell |
6,472
-497
| -7% | -$27.4K | 0.1% | 131 |
|
|
2020
Q4 | $373K | Buy |
6,969
+78
| +1% | +$4.05K | 0.1% | 134 |
|
|
2020
Q3 | $324K | Sell |
6,891
-788
| -10% | -$40.4K | 0.1% | 131 |
|
|
2020
Q2 | $401K | Hold |
7,679
| – | – | 0.15% | 101 |
|
|
2020
Q1 | $364K | Buy |
7,679
+231
| +3% | +$12K | 0.15% | 99 |
|
|
2019
Q4 | $377K | Buy |
7,448
+110
| +1% | +$5.68K | 0.15% | 123 |
|
|
2019
Q3 | $346K | Buy |
7,338
+1,239
| +20% | +$56.6K | 0.15% | 128 |
|
|
2019
Q2 | $287K | Buy |
6,099
+550
| +10% | +$25.4K | 0.14% | 119 |
|
|
2019
Q1 | $267K | Sell |
5,549
-26
| -0.5% | -$1.3K | 0.14% | 116 |
|
|
2018
Q4 | $249K | Buy |
+5,575
| New | +$291K | 0.15% | 114 |
|
Other funds holding CAH
Mirador Capital Partners's CAH Position: Q2 2026 in Review
Mirador Capital Partners reduced its Cardinal Health (CAH) stake by 2% in Q2 2026, selling an estimated $41.1K and leaving 9,845 shares worth $2.34M. The position accounts for 0.29% of the portfolio, ranked #63.
Mirador Capital Partners first reported a position in CAH in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.36M in Q2 2025. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Mirador Capital Partners held 9,845 shares of Cardinal Health worth $2.34M as of Q2 2026.
- Mirador Capital Partners sold 198 Cardinal Health shares in Q2 2026, an estimated $41.1K.
- Cardinal Health made up 0.29% of Mirador Capital Partners's portfolio in Q2 2026, its #63 holding.
- Mirador Capital Partners first reported a position in Cardinal Health in Q4 2018 and has held it in 31 quarters since.
- Mirador Capital Partners's Cardinal Health position peaked at $2.36M in Q2 2025.
- 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.